Term ends Jul 25, 2033 · High confidence
20-year base term ends Jul 25, 2033
Held by AngioDynamics, Inc.
Filed Dec 9, 2013 as application 14/100,671 · Granted Nov 4, 2014
Base term, 20 years from filing
Today
2013
2033
Clock starts
Jul 25, 2013
Jul 25, 2013
Term ends
Jul 25, 2033
Jul 25, 2033
Granted
Nov 4, 2014
Nov 4, 2014
base term
fee events
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 8,603,070, to Jul 25, 2033. The term already ends on or before that date, so the cap shortened nothing.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
9
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jul 25, 2013, when application 13/950,592, the earliest non-provisional in its chain, was filed (this one was filed Dec 9, 2013) | Jul 25, 2033 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 8,603,070) | resolves to Jul 25, 2033, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Jul 25, 2033 | High confidence |
This family
| US 8,317,773 | In force Oct 2028 | Oct 2028 |
| Application 12/046,926 | Abandoned not computed | not computed |
| Application 12/392,220 | Abandoned not computed | not computed |
| US 8,603,070 | In force Jul 2033 | Jul 2033 |
| US 8,876,797 | this patent Jul 2033 | Jul 2033 |
| Application 14/151,267 | Abandoned not computed | not computed |
| US 9,731,049 | In force Oct 2033 | Oct 2033 |
| US 9,867,908 | Term ended Nov 2026 | Nov 2026 |
8 of 9 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Apr 3, 2014 Reel 32596, frame 910 | Santerre, J. Paul; Ho, Jeannette | Interface Biologics Inc. | Assignment of Assignor's Interest |
| Nov 8, 2016 Reel 40613, frame 49 | AngioDynamics, Inc. | JPMorgan Chase Bank, N.A., as Administrative Agent | Security Interest |
| Jun 5, 2019 Reel 49371, frame 657 | AngioDynamics, Inc. | JPMorgan Chase Bank, N.A., as Administrative Agent | Confirmatory Grant of Security Interest in United States Patents |
| Oct 10, 2019 Reel 50683, frame 425 | Interface Biologics, Inc. | Evonik Canada Inc. | Assignment of Assignor's Interest |
| Aug 31, 2022 Reel 61360, frame 668 | AngioDynamics, Inc. | JPMorgan Chase Bank, N.A., as Administrative Agent | Security Interest |
| Aug 31, 2022 Reel 61363, frame 446 | JPMorgan Chase Bank, N.A., as Administrative Agent | AngioDynamics, Inc. | Release of Security Interest |
| May 9, 2023 Reel 63579, frame 256 | Lareau, Raymond; Bell, Benjamin | AngioDynamics, Inc. | Assignment of Assignor's Interest |
| Jun 8, 2023 Reel 63940, frame 362 | JPMorgan Chase Bank, N.A., as Administrative Agent | AngioDynamics, Inc. | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Jul 2033
Term ends Jul 25, 2033. No further fees fall due before then
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 8,603,070, ends no earlier than this term, so it caps nothing.
Citations
10
later US patents cite this one
That is above the median of utility patents granted in 2014 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.